This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:patients:protocol_overview [07.03.2017] – [Introduction to the Marshall Protocol] duration determined + by the level of immune dysregulation which has occurred and the unavoidable immune suppressants to which the patient is exposed sallieq | home:patients:protocol_overview [07.31.2018] – [Medications used] sallieq | ||
---|---|---|---|
Line 18: | Line 18: | ||
The objective of the MP is to safely activate a [[home: | The objective of the MP is to safely activate a [[home: | ||
- | Treatment on the MP requires a [[home: | + | Treatment on the MP requires a [[home: |
The MP is to be administered only by a [[home: | The MP is to be administered only by a [[home: | ||
Line 24: | Line 24: | ||
===== Medications used ===== | ===== Medications used ===== | ||
+ | |||
+ | The document [[home: | ||
+ | |||
+ | Without active participation of patients on MarshallProtocol.com site, Autoimmunity Research Foundation does not support or license the public use of this therapy. | ||
- | {{section>: | ||